26 research outputs found

    The renal blood flow reserve in healthy humans and patients with atherosclerotic renovascular disease measured by positron emission tomography using [O-15]H2O

    Get PDF
    Background: Microvascular function plays an important role in ARVD (atherosclerotic renovascular disease). RFR (renal flow reserve), the capacity of renal vasculature to dilate, is known to reflect renal microvascular function. In this pilot study, we assessed PET (positron emission tomography)-based RFR values of healthy persons and renal artery stenosis patients.Seventeen patients with ARVD and eight healthy subjects were included in the study. Intravenous enalapril 1 mg was used as a vasodilatant, and the maximum response (blood pressure and RFR) to it was measured at 40 min. Renal perfusion was measured by means of oxygen-15-labeled water PET. RFR was calculated as a difference of stress flow and basal flow and was expressed as percent [(stress blood flow - basal blood flow)/basal blood flow] x 100%.Results: RFR of the healthy was 22%. RFR of the stenosed kidneys of bilateral stenosis patients (27%) was higher than that of the stenosed kidneys of unilateral stenosis patients (15%). RFR of the contralateral kidneys of unilateral stenosis patients was 21%. There was no difference of statistical significance between RFR values of ARVD subgroups or between ARVD subgroups and the healthy. In the stenosed kidneys of unilateral ARVD patients, stenosis grade of the renal artery correlated negatively with basal (p = 0.04) and stress flow (p = 0.02). Dispersion of RFR values was high.Conclusions: This study is the first to report [O-15]H2O PET-based RFR values of healthy subjects and ARVD patients in humans. The difference between RFR values of ARVD patients and the healthy did not reach statistical significance perhaps because of high dispersion of RFR values. [O-15]H2O PET is a valuable non-invasive and quantitative method to evaluate renal blood flow though high dispersion makes imaging challenging. Larger studies are needed to get more information about [O-15]H2O PET method in evaluation of renal blood flow

    Terveydenhuollon kansalliset laaturekisteripilotit loppusuoralla

    Get PDF
    Pilottiprojektin tulokset laaturekisterien toiminnan organisoimisesta kannustavat ­jatkamaan työtä moniammatillisesti ja pitkäjänteisesti. Kansallinen koordinaatio on välttämätöntä laatu- ja vaikuttavuustiedon vertailukelpoisuuden ja hyödyntämisen varmistamiseksi

    Kustannusseuranta - Syntyikö säästöä, paraniko tuottavuus?

    No full text

    Muuttuiko avoterveydenhuollon palvelujen käyttö?

    No full text

    Nisäkkäät. Mammalia. Mammals

    No full text

    The 2015 red list of Finnish mammal species

    Get PDF
    Suomen nisäkäslajien uhanalaisuus arvioitiin 2015 Kansainvälisen luonnonsuojeluliiton (IUCN) laatimien kriteerien ja luokituksen perusteella. Punaiselle listalle päätyvät uhanalaiset, hävinneet, silmälläpidettävät ja puutteellisesti tunnetut lajit. Tässä julkaisussa esitellään Suomen punaisen listan nisäkäslajit, niiden uhanalaisuusluokat, luokittelun kriteerit, elinympäristöt, uhanalaisuuden syyt ja uhkatekijät.Piirrokset / Drawings: Terhi Ryttäri. Layout: Satu TurtiainenArvioinnit on käsitelty ja hyväksytty Lajien uhanalaisuuden arvioinnin ohjausryhmässä (LAUHA).201

    Enhancing identification of nonaffective psychosis in register-based studies

    No full text
    Abstract The Finnish Quality of Psychosis Care Register assesses nonaffective psychosis (NAP) care, acknowledging treatment outside specialized psychiatric services. This approach, while providing a holistic view, raises concerns about diagnostic inaccuracies. Here, we studied situations where the register-based diagnosis might be inaccurate, and whether the first episode can be reliably identified using a 14-year wash-out period. People with first register-based NAP (ICD-10 F20-F29) between years 2010 and 2018 and without NAP diagnoses in 1996–2009 were identified from the Care Register for Health Care. A diagnosis of NAP was deemed unreliable before age 7, when dementia preceded NAP diagnosis, and when a NAP diagnosis had been assigned at admission or during psychiatric hospitalization but was not confirmed by discharge diagnosis. Despite a 14-year follow-back the first register diagnosis may miss the first treatment episode in older patients. Register-based studies on psychotic disorders should pay attention to exclusion criteria and to the definition of treatment onset
    corecore